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ABSTRACT Severe malarial anemia (SMA) in semi-immune individuals eliminates both infected and uninfected erythrocytes and
is a frequent fatal complication. It is proportional not to circulating parasitemia but total parasite mass (sequestered) in the or-
gans. Thus, immune responses that clear parasites in organs may trigger changes leading to anemia. Here, we use an outbred-rat
model where increasing parasite removal in the spleen escalated uninfected-erythrocyte removal. Splenic parasite clearance was
associated with activated CD8 T cells, immunodepletion of which prevented parasite clearance. CD8 T cell repletion and con-
comitant reduction of the parasite load was associated with exacerbated (40 to 60%) hemoglobin loss and changes in properties
of uninfected erythrocytes. Together, these data suggest that CD8 T cell-dependent parasite clearance causes erythrocyte re-
moval in the spleen and thus anemia. In children infected with the humanmalaria parasite Plasmodium falciparum, elevation of
parasite biomass (not the number of circulating parasites) increased the odds ratio for SMA by 3.5-fold (95% confidence inter-
vals [CI95%], 1.8- to 7.5-fold). CD8 T cell expansion/activation independently increased the odds ratio by 2.4-fold (CI95%, 1.0- to
5.7-fold). Concomitant increases in both conferred a 7-fold (CI95%, 1.9- to 27.4-fold)-greater risk for SMA. Together, these data
suggest that CD8-dependent parasite clearance may predispose individuals to uninfected-erythrocyte loss and SMA, thus in-
forming severe disease diagnosis and strategies for vaccine development.
IMPORTANCE Malaria is a major global health problem. Severe malaria anemia (SMA) is a complex disease associated with par-
tial immunity. Rapid hemoglobin reductions of 20 to 50% are commonly observed andmust be rescued by transfusion (which
can carry a risk of HIV acquisition). The causes and risk factors of SMA remain poorly understood. Recent studies suggest that
SMA is linked to parasite biomass sequestered in organs. This led us to investigate whether immunemechanisms that clear para-
sites in organs trigger anemia. In rats, erythropoiesis is largely restricted to the bone marrow, and critical aspects of the spleen
expected to be important in anemia are similar to those in humans. Therefore, using a rat model, we show that severe anemia is
caused through CD8 T cell-dependent parasite clearance and erythrocyte removal in the spleen. CD8 activationmay also be a
new risk factor for SMA in African children.
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Malaria continues to be a major health challenge in the world.Plasmodium falciparum causes the most virulent form of
human malaria. In 2012, it killed over 600,000 children, largely in
sub-Saharan Africa (1). The asexual-blood-stage parasite infects
erythrocytes and is responsible for all of the symptoms and pathol-
ogy associated with disease. Uncomplicated malaria consists of
cycles of high fever and chills. Severe malaria includes additional
pathologies, including anemia, respiratory distress, lactic acidosis,
and cerebral malaria (2).
Severe malaria greatly increases the risk of death. The major
pathophysiological state is severe malarial anemia (SMA). SMA is
a complex disease, associated with partial immunity and results
from the loss of both uninfected and infected erythrocytes, along
with a concomitant block in erythropoiesis (2–4). Rapid hemo-
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globin reductions of 20 to 50% are commonly observed (5) and
must be rescued by transfusion (which can carry a risk of other
infections). However, the cause of this reduction and whether it
also inexplicably influences dyserythropoiesis remain poorly un-
derstood. SMA in human populations is not proportional to cir-
culating parasitemia, and recent studies suggest that it is linked to
total parasite biomass sequestered in organs (6, 7). This led us to
query whether immune mechanisms that kill parasites in organs
may trigger anemia.
Mechanistic investigation can be greatly facilitated by relevant
animal models and organ systems with physiological correspon-
dence to human systems. Malarial anemia has previously been
investigated in several mice and rat models (8–11). Murine mod-
els are attractive due to the availability of genetics and related
tools. However, one drawback is that erythropoiesis, which in hu-
mans is in the bone marrow, is anomalously active in the mouse
spleen (especially in response to a stress like anemia) (9, 12). This
profoundly influences the organizational and functional compo-
nents of an organ expected to be important in erythrocyte re-
moval, a major mechanism of anemia (9). In contrast, in rats,
erythropoiesis is largely restricted to the bone marrow, and critical
aspects of the spleen red pulp architecture are similar to those of
humans (13, 14). Hence, the pathophysiology of human splenic
disease is likely to be better mimicked and measured in rats, whose
larger size also facilitates monitoring anemia. Here, we have uti-
lized the Wistar rat model, where malarial anemia is due to eryth-
rocyte removal rather than dyserythropoiesis (8). We elucidate
splenic mechanisms that exacerbate anemia by erythrocyte re-
moval (up to ~50 to 60% hemoglobin reduction). We further
extend these findings to patient studies and thus identify new risk
factors for SMA in African children.
RESULTS
Comparative analysis of spleens and livers from aged Wistar rats
infected with Plasmodium berghei ANKA reveals that the spleen
shows mass expansion associated with anemia and the major par-
asite burden.
Rats infected with wild-type P. berghei ANKA displayed low
peripheral parasitemia (3%) that peaked at day 8 postinfection
(p.i.) (Fig. 1A). At day 10, peripheral parasitemia and the hemat-
ocrit declined. By days 12 to 14, parasites were completely elimi-
nated, with an ~20% reduction in the hematocrit (range, 16 to
40%), suggesting simultaneous clearance of both infected and un-
infected erythrocytes (the variation in hematocrit reduction is
characteristic of an outbred model [8, 10]). The subsequent ro-
bust increase of reticulocytes (Fig. 1B) confirmed that erythrocyte
reduction (or anemia) was not due to a block in erythropoiesis.
Rather, it was by removal of uninfected erythrocytes (since the
hematocrit declined 20% at 3% parasitemia). After recovery from
anemia (days 24 to 28), the animals were cured and immune to
subsequent parasite challenge (8, 10).
Since this is a model of malarial anemia, the spleen and the liver
are expected to be the major affected organs. Notably, there was,
on average, a 5-fold increase in spleen mass but no increase in
liver mass by day 10 (Fig. 1C). Elevation of mean corpuscular
volume (MCV) and mean corpuscular hemoglobin (MCH),
highly characteristic of stress erythropoiesis, in the bone marrow
(as in humans) was also noted (Fig. 1D and E), suggesting that the
splenic expansion shown in Fig. 1C was not linked to increased
splenic erythropoiesis (as in murine systems) but that it may play
a major role in the removal of infected and uninfected erythro-
cytes.
Anemia has been linked to total parasite biomass in organs in
human falciparum malaria (7). Quantitative PCR (qPCR) re-
vealed that at day 8 (of peak infection), the rat spleen was the
major site of P. berghei burden, containing over 70% of the para-
sites (Fig. 1F, upper panel). By day 10, there was a 34-fold reduc-
tion in the number of parasites in the spleen (to levels lower than
in the liver, which remained unchanged), and the dynamics of
splenic clearance was the same for wild-type and mutant parasites
(10). Pathological analyses of lung, kidney, and brain failed to
reveal significant parasite material compared to that in the spleen
or even the liver (see Fig. S1 in the supplemental material). The
lung showed small mass fluctuations, but they were largely reduc-
tions, and their dynamics were not coincident with peak infection,
numbers of detectable parasites, or anemia (see Table S1). To-
gether, these data suggested that spleen was the major site of par-
asite burden. Moreover, the timing of parasite elimination was
also that of erythrocyte clearance and anemia.
We further investigated a P. berghei ANKA mutant with a de-
letion of msp7, a gene implicated in blood cell invasion and thus
likely to influence total parasite load and anemia (10). At day 8,
there was no difference in parasite loads in the liver, but in the
spleen, the msp7 strain’s peak load was 3-fold lower than that of
its wild-type counterpart (Fig. 1F). msp7 strain clearance was
coincident with a 14-fold reduction in spleen parasites at day 10
and a 10% reduction of uninfected erythrocytes at day 12
(Fig. 1F). This comparative analysis of the msp7 and wild-type
parasites suggested that increasing fold parasite clearance in the
spleen escalated uninfected-erythrocyte removal and thus anemia.
Expansion of splenic CD8 T cells, in wild type relative to
msp7 infection. To understand in an unbiased way splenic pro-
cesses that underlie increased clearance of parasite load (rather
than overall infection per se), we examined differences in host
response to wild-type parasites relative to msp7 mutant para-
sites. To do this, we undertook whole-genome microarray expres-
sion analyses of wild-type- relative to mutant-infected spleens at
day 10 (uninfected animals were also included as controls)
(Fig. S2A). Three hundred seventy-seven genes showed significant
changes in expression (1.5-fold change, P 0.005) (Table S2A).
In the top network (Fig. 2A), 7 (of the top 20) genes were for
granzymes (including granzyme B), suggesting involvement of
CD8 T cells or NK cells.
Flow cytometry analyses confirmed that P. berghei infection
induced infiltration of B cells, NK cells, and CD3 T cells (both
CD8 and CD4 T cells) in the spleen (see the combined infor-
mation of Fig. 2B and C and S2B and C). NK cell counts remained
low, with no difference seen between wild-type- and mutant-
infected spleens (Fig. 2B), which also showed no significant differ-
ences in B cell counts (Fig. S2B). Wild-type-associated elevation
was seen in CD3 T cells, with a 1.5-fold increase in CD8 T cells
on day 10 in wild-type- compared tomsp7 mutant-infected cells
(Fig. 2C).
Quantitative immunohistochemical (IHC) analyses of spleen
zones revealed that compared tomsp7 mutant-infected animals,
wild-type-infected animals showed specific, 2-fold increases in
CD8 T cell concentrations in the white pulp/periarteriolar lym-
phoid sheaths and marginal zone (WP/PALS and MZ) at day 8
(Fig. 2D). By day 10, the CD8T cells had migrated to the red pulp
(RP) (Fig. 2D and S2C and D). The 2-fold increase in specific
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splenic zones detected by IHC analysis corresponded well to the
1.5-fold increase detected in the whole spleen by flow cytometry.
IHC analysis showed no statistically significant differences in
numbers of CD4 T cells or macrophages (Fig. S3). Although
wild-type infections showed modest increases in CD8 and CD4
T cells in the liver (Fig. S4), the absolute number of CD8 and
CD4 T cells in the spleen were 8- to 10-fold higher than in the
liver (Table S3). Numbers of CD68 cells were also increased in
spleen (Table S3).
Together, these data revealed that in wild-type relative to
msp7 mutant infection, the major immune cell differences were
in the spleen. Moreover, at day 10, the onset of parasite clearance,
there was elevation in the number of CD8T cells in the spleen RP
(where parasites are eliminated), suggesting that CD8 T cells
may be linked to blood-stage parasite clearance.
Requirement of CD8T cells: effects on parasite control and
anemia. The requirement for CD8 T cells in controlling blood-
stage infection was tested in rats injected with anti-CD8
(Fig. 3A), which led to depletion of 95% of CD8 T cells
(Fig. 3B, left side). Levels of CD4T cells (Fig. 3B, right panel) and
other immune cells (Fig. S5A and B) were unaffected. CD8T cell
depletion had no significant effect on the rise in parasitemia or
peak parasitemia. It blocked subsequent reduction of parasitemia
(Fig. 3C), sustaining it through day 10 to 12, when parasites are
usually eliminated. A time course of CD8 T cell repletion sug-
gests high-level restoration on day 15 and later (Fig. 3D). Immu-
FIG 1 In aged Wistar rats, the spleen is the major site of parasite burden and clearance. (A to E) Malarial anemia induced by P. berghei ANKA in aged Wistar
rats. (A to C) Anemia (filled circles) is measured as a reduction in hematocrit (right-panel y axis scale). (A) Dynamics of peripheral parasitemias in infected rats
(filled triangles) and hematocrits in uninfected rats (open circles); (B) reticulocytosis (filled diamonds) and hematocrits (filled circles); (C) mass change in
spleens (filled squares) and livers (multiplication signs). Dynamics of mean corpuscular volume (MCV) (D) and mean corpuscular hemoglobin (MCH) (E) are
also shown for infected (filled circles) and uninfected (open circles) rats. (F) Comparative analysis of relative parasite mass and its change in the spleen and liver,
correlated with anemia. Ratios of spleen and liver parasite loads were established by qPCR from rats infected with wild-type ormsp7 parasites at (i) the peak of
infection on day 8 and (ii) parasite reduction (Par. reduct.) day 10 (D10), suggesting 3- to 4-fold-higher levels of wild-type than of mutant parasites in the spleen
on day 8; in contrast, the day 8 peak peripheral parasitemia of the wild-type parasites was 3%, compared to 2% formsp7mutant parasites, but the dynamics were
unchanged (10; data not shown). Maximal hematocrit reduction (Hcte reduct.), i.e., peak anemia, was measured at day 12. The time point selection in panel F
was based on time points in panels A to C, and the time course of peak infection and anemia induced by the msp7 mutant was identical to that seen with
wild-type parasites (10). The fold spleen parasite clearance and percent hematocrit reduction were ~2-fold higher in rats infected with the wild type (34-fold,
20%) than in rats infected with the msp7 mutant (14-fold, 10%). For panels A to E, the mean values and standard deviations are as shown. The data presented
are representative and are from one out of two independent experiments with 3 to 4 animals in each group and for each time point. For the mean comparisons
in panel F, one-way ANOVA with a Tukey post hoc analysis was used.
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nohistochemical analysis at day 10 revealed that anti-CD8 re-
sulted in a 2- to 3-fold reduction of splenic CD8 T cells (Fig. 3E
and F), with no effect on dendritic cells (see also Fig. S5C and D),
and in an elevation of splenic parasites (Fig. 3G). Repletion in CD8
T cells and the associated parasite clearance resulted in a deeper
anemia (40% hemoglobin loss) (Fig. 3H).
Neither parasites alone (days 0 to 5) nor CD8 T cells alone
(days 18 to 22) induced anemia. Both were detected from days 6 to
16, and during the adaptive phase (days 10 to 14), parasite clear-
ance mediated by CD8 T cells was associated with severe anemia
(Fig. 3H). The anemia was followed with a significant increase in
the number of reticulocytes in the peripheral circulation (Fig. 3I),
with characteristics of bone marrow-associated erythropoiesis
(Fig. S5E to H). Moreover, since the peak parasitemias achieved
were ~3%, 40 to 60% anemia was principally due to removal of
uninfected red blood cells, as expected in this model. Analysis of
the dynamics in individual animals (showing interanimal vari-
ability in outbred species) further confirmed the association be-
tween the requirement of parasitemia and CD8 T cells and ane-
mia (Fig. S6). Together, these data suggest that CD8 T cells
regulate the clearance of parasites, which in turn induces anemia.
Activation of CD8 T cells in the spleen is proportional to
parasite load in the organ and soluble CD8 (sCD8) in plasma.
Because CD8 T cells regulate parasite clearance, day 10 is the
onset of clearance, and the RP is a major site (15), we investigated
the activation of CD8 T cells at this time point in the spleen.
Unfortunately, there are only a limited number of well-developed
markers for cellular analysis in rats. As an alternative, we used
microarray data that yielded extensive, genome-wide activation
readouts and compared them to transcriptional signatures char-
acteristic of murine CD8 T cell activation elicited by viral and
bacterial infections (16). These analyses revealed expression pat-
terns typical of effector CD8 T cells (downregulation of the in-
terleukin 7 receptor [IL-7R] and Bcl-2 and upregulation of E2Fs)
in splenocytes infected with the wild type and mutant compared
to their uninfected counterparts (Fig. 4A; Table S2B). Further,
among the differentially expressed genes in rats infected with the
wild type versus the mutant, there are several (such as the gran-
zyme genes) in common with those identified in murine effector
CD8 T cells (Fig. 4A).
Numbers of activated splenic CD8 T cells were proportional
to parasite load in the organ (Fig. 4B). We also examined sCD8,
FIG 2 Expansion of CD8 T cells in the rat spleens upon infection with wild-type relative to msp7 parasites. (A) Inflammatory and immunological disease
pathways predicted by ingenuity pathway analysis (IPA) of gene expression induced by wild-type relative tomsp7 parasites on day 10. Red, highly upregulated
genes (such as those for the granzymes GZM A and B); pink, genes with moderately increased expression (GZM K, CXCL10, CCL4 S100, and other inflammatory
markers); green, downregulated genes. A full list of rat gene transcripts elevated in rats infected with wild-type relative to mutant parasites is shown in Table S2.
(B and C) Flow cytometric analysis of NK cells (CD161A) and CD3 T and CD8 T cells from spleens of animals infected with wild-type (Wt) ormsp7 mutant
parasites at day 8 (D8) and day 10 (D10) p.i. (D) Immunohistochemical staining of CD8 T cells in the spleens of uninfected and wild-type- or msp7
parasite-infected rats at day 8 or 10 p.i. The CD8T cell density was significantly higher in infected than in uninfected animals (although very low levels of CD8
T cells are seen in uninfected spleens [see the yellow circle in panel D1, which is magnified further in Fig. S2C]). Quantitative analysis (results are shown in
Fig. S2D) confirmed that wild-type infection resulted in higher numbers of CD8 T cells than msp7 mutant infection. In addition, in wild-type-parasite
infections, CD8 T cells were more highly concentrated in the white pulp (WP) or marginal zone (MZ) on day 8 and in the red pulp (RP) on day 10. PALS,
periarteriolar lymphoid sheath. Original magnifications,100 (D1 to -6),400 (D7 to -9).
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because it is a form of the receptor released after activation (17,
18). sCD8 has been reported to be derived from CD4 T cells in
certain circumstances of viral infection, autoimmunity, and trans-
plantation (19). However, in our model, the CD4T cell response
is not altered between wild-type and msp7 mutant infections
(Fig. S2) and CD4 T cell numbers were not reduced when rats
were perfused with anti-CD8 that immunodepleted CD8 T
cells (Fig. 3 and S5A), suggesting that the CD4 CD8 T cell
subpopulation is not induced in malarial infection. Indeed, we
find that plasma sCD8 levels strongly and positively correlated
with CD8 T cell number (Fig. 4C) (Spearman r  0.9, P 
0.0001) and parasite load (Fig. 4D) (Spearman r 0.8, P 0.20).
Activated CD8 T cells are known to directly kill intracellular
pathogens (20–22). This requires antigen presentation by the ma-
jor histocompatibility complex (MHC) class I, which we detected
on both uninfected and infected reticulocytes as well as white cells
(Fig. 4E). We further detected specific production of gamma in-
terferon (IFN-) by CD8 T cells stimulated with infected reticu-
FIG 3 Effect of CD8 T cell depletion on parasitemia, the reticulocyte response, and anemia. (A) Experimental timeline of immunodepletion of CD8 T cells,
time of antibody and parasite injection, and sampling of immune cells and other indicated parameters over 28 days (see also Materials and Methods). (B) Flow
cytometry analysis at day 0, confirmed depletion of peripheral CD8 T cells in animals treated with anti-CD8 (left side) compared to isotype control Ab (right
side). PBMCs were also stained for CD4, CD3, and B (CD45RA) markers and analyzed by flow cytometry. (C) Depletion of CD8T cells showed no effect on the
rise of parasitemia, but on day 12, when parasites were eliminated in isotype controls (filled squares), they remained at peak values in depleted animals (filled
circles). (D) Dynamics of peripheral CD8 T cells (expressed as a fraction of total CD3 T cells) in animals treated with anti-rat CD8 (filled circles) or isotype
control antibodies (filled squares), as well as in untreated (filled triangles) animals. Infected animals have higher levels of CD8 T cells than uninfected animals.
However, after anti-CD8 treatment, CD8 T cell levels remained undetectable for 5 days in infected animals. From days 5 to 18, they rose and reached state
levels. (E) Distribution of CD8T cells (stained brown) in the spleens of isotype control and immunodepleted animals on day 10 as detected by IHC analysis. (F)
Quantification of CD8 T cells in panel E. (G) Parasite loads in the spleens (detected by qPCR) of immunodepleted animals are higher than in isotype controls
on day 10. Norm. Quant, normal quantity. (H) Induction of anemia (unbroken lines) as measured by the percent hemoglobin reduction (left-side y axis) in
animals treated with anti-rat CD8 (filled circles) and isotype control antibodies (filled squares), as well as in untreated (filled triangles) animals. Associated
peripheral parasitemias (right-side y axis) and their clearance are shown with dashed lines. (I) The reticulocyte response was increased in animals treated with
anti-CD8 Ab (filled circles) compared to that in animals treated with the isotype control (filled squares). Mean values and standard deviations are shown in
panels C, D, H, and I. The data are representative of one experiment of three independent experiments that contained 5 to 6 animals in each treatment group. For
the mean comparisons, one-way ANOVA with a Tukey post hoc analysis (F) and Student’s t test (G) were used.
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locytes in vitro (Fig. 4F), although the number of CD8T cells and
infected cells were limiting because they were from the same ani-
mal (since this is an outbred model). Although we show that
CD8 T cells are (i) activated in response to blood-stage infection
in vitro and (ii) control parasitemia in vivo, the lack of information
on MHC class I presentation in this outbred rat model precludes
establishing whether activation is indirectly or directly stimulated
by infected erythrocytes.
Changes in properties of uninfected erythrocytes inmalarial
anemia. Under physiological conditions, the spleen is the major
site of clearance of (aged and altered) erythrocytes. Since splenic
clearance mechanisms detect changes in cellular properties of
erythrocytes, we examined peripheral erythrocytes from infected
rats on discontinuous Percoll gradients (Fig. 5A and B). On these
gradients, infected erythrocytes (asterisk in Fig. 5A) and reticulo-
cytes (Fig. 5A) were detected in the top light fraction (48%), while
uninfected erythrocytes were detected at intermediate and higher
densities (50% and greater). Visual representation and cell counts
of various density fractions on different days suggested that infec-
tion increases the relative density of uninfected erythrocytes. As
shown in Fig. 5B, at day 12 (a time of active erythrocyte removal),
uninfected erythrocytes from all three infected animals consis-
tently showed higher density fractions at 54%, 58%, and 60%
Percoll, accounting for 20 to 40% of erythrocytes, which well cor-
responds to the extent of erythrocyte removal seen in this animal
model. Since the spleen also has high concentrations of erythro-
cytes, we propose a splenic model for erythrocyte clearance asso-
ciated with severe anemia (Fig. 5Ci and Cii). Here, parasite elim-
ination results in the alteration of uninfected erythrocytes to limit
their filtration through the spleen as well as to potentiate their
removal by activated macrophages.
Elevationof theCD8Tcell responseassociatedwithSMAin
a case-control pediatric cohort infected with P. falciparum.
Since the rat model is expected to better mimic the pathophysiol-
ogy of human disease, the relevance of our findings to patient
populations was investigated in a case-control pediatric cohort
from Ibadan, Nigeria. The study design and details of clinical case
definition are included in Materials and Methods. As shown in
FIG 4 Activation of splenic CD8 T cells, which is proportional to the parasite load in the organ and sCD8 released into the plasma. (A) Rat gene transcripts
that are elevated in wild-type-parasite relative to msp7 mutant infections (Table S2A) and also found in murine CD8 T cell activation (16). Fold change is
shown in parenthesis. In bold are additional genes typical of effector CD8 T cells seen in wild-type-parasite- and mutant-parasite-infected splenocytes relative
to their uninfected counterparts (see also Table S2B). Italicized, underlined genes are downregulated. (B) Quantification of CD8 T cells (detected by immu-
nohistochemistry) indicates that they are directly proportion to parasite load (detected by qPCR) in the spleen. (C) Plasma levels of sCD8 (detected by ELISA)
are directly proportional to CD8 T cell numbers quantified in the spleen. (D) Plasma levels of sCD8 are directly proportional to parasite load in the spleen. The
Spearman correlation coefficient was used to determine the correlation shown in panels B to D. (E) Detection of MHC class I on uninfected and infected
reticulocytes. Blood specimens from infected animals were labeled with the indicated primary antibodies directly conjugated to fluorescent chromophores in
live-cell assays (see also Materials and Methods) to detect CD71 (a transferrin receptor, a marker for reticulocytes [red]), MHC class I (green), and DAPI (to label
parasite or host nuclei [blue]) and viewed by Delta vision deconvolution microscopy. Marker distribution detected on uninfected and P. berghei-infected
reticulocytes and a white cell are shown. (F) In vitro stimulation of day 10, CD8T cells by P. berghei-infected erythrocytes taken from the same animals (see also
Materials and Methods), measured by IFN- production. Median values of IFN- production by bacterial SEB antigen (positive control) are shown. Student’s
t test was used for the mean comparisons. PbA, P. berghei ANKA; RBC, red blood cells.
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Fig. 6, plasma specimens from 268 children between the ages of 6
and 149 months (13 years) were analyzed. Two hundred eleven
P. falciparum-infected children without neurological symptoms
were separated on the basis of packed cell volume (PCV) into the
SMA group (PCV, 5 to 15%; n 48) and uncomplicated malaria
(UM) group (PCV, 16 to 45%; n  163). The UM group was
further subdivided into groups with acute infection with no ma-
larial anemia (AINMA) (PCV, 29 to 45%; n 92) and mild ma-
larial anemia (MMA) (PCV, 16 to 28%; n  71). Also included
were plasma samples from 57 age-matched community controls
(CC) (PCV, 30 to 42%).
P. falciparum histidine-rich protein 2 (PfHRP2), the lead
marker used to estimate total parasite mass (6, 7), was detected in
over 89% of patient samples across disease groups (Fig. 6A). We
found that higher plasma concentrations of PfHRP2 (and not pe-
ripheral parasitemia) were associated with SMA (Fig. 6B, section
I). When the UM (AINMA and MMA) and SMA groups were
combined, PCV levels inversely and significantly correlated with
plasma levels of PfHRP2 (r  to 0.43; P  0.0001) or with esti-
mated total parasite biomass (r to 0.42; P 0.0001).
sCD8 was also significantly increased for SMA patients com-
pared to levels in the CC (P  0.004), AINMA (P  0.09), or
MMA (P 0.021) group, although there was considerable varia-
tion in the data in all groups (Fig. 6B, section II). In humans,
CD8 T cell levels may reflect responses to liver infection (al-
though this will not be reflected in the PfHRP2 biomass). None-
theless, a univariate logistic regression analysis indicated that age
(odds ratio [OR], 0.3-fold; 95% confidence intervals [CI95%], 0.2-
to 0.6-fold) and weight (OR, 0.4-fold; CI95%, 0.2- to 0.7-fold])
were significantly associated with a decreased risk of SMA in chil-
dren (Table 1). However, this risk increased when the plasma con-
centrations of PfHRP2 (OR, 3.5-fold; CI95%, 1.7- to 7.1-fold) (but
not peripheral parasitemia) or the estimated total parasite bio-
mass (OR, 3.7-fold; CI95%, 1.8- to 7.5-fold) (but not the number of
FIG 5 Properties of uninfected erythrocytes are altered in the P. berghei ANKA infection/anemia model. (A) Visual representation of total blood obtained from
uninfected (Uninf) and infected rats fractionated on Percoll density gradients on the indicated days after the onset of infection. On these gradients, infected
erythrocytes ( in panel A) and reticulocytes (# in panel A) are detected in the top light fraction (48% Percoll), while uninfected erythrocytes are detected at
intermediate and higher densities (50% and greater). (B) Cell counts of the different density fractions suggest that infection increases with the relative density of
uninfected erythrocytes. Analyses shown for blood from an uninfected rat and three individual infected rats at day 12 (a time of active erythrocyte removal and
production of new reticulocytes marked by #) indicates that uninfected erythrocytes from all three infected animals were consistently detected in the higher-
density fractions of 54%, 58%, and 60% Percoll. (C) Spleen red pulp and a model for erythrocyte removal. (Ci) H&E stain of infected spleen red pulp showing
high concentrations of erythrocytes (red), macrophages (MF), cords (CO), and sinus lumen (SL). (Cii) Multiple mechanisms of erythrocyte removal in the
spleen. Parasite killing in the red pulp, through direct mechanisms (CD8 T cell dependent [no. 1]) and indirect mechanisms (such as presentation via dendritic
cells and macrophages [no. 2 and 3]) may activate macrophages to trigger erythrocyte removal. Parasite killing may also induce changes in uninfected-erythrocyte
properties, further enhancing their removal by activated macrophages (). Changes in erythrocyte properties may limit their squeezing () through the sinusoids
(blue barrel), resulting in entrapment in the red pulp and subsequent removal there. All three processes are likely to work in conjunction, leading to SMA.
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circulating parasites) were elevated. The risk of SMA also in-
creased when plasma sCD8 (OR, 2.4-fold; CI95%, 1.0- to 5.7-fold)
was elevated (Table 1). Notably, the concomitant elevation in both
plasma parameters was associated with a significant increased risk
of SMA (OR, 7.2-fold; CI95%, 1.9- to 27.4-fold), suggesting that
activated CD8 T cells and parasite biomass may act in conjunc-
tion, as predicted from the rat model. In infected children, this
association was observed even after adjustment for age and weight
(adjusted OR, 6.7-fold; CI95%, 1.7- to 25.7-fold) (Table 1).
DISCUSSION
Multiple host factors are known to influence malarial anemia (2,
23), but these are innate mechanisms (4, 24, 25). P. berghei-in-
fected rats have historically been used to study anemia (26, 27).
The rat spleen confers T cell immunity (28). CD4 T cells were
proposed to eliminate anemia in a murine malaria model (8), but
the study lacked quantitation of both CD4 and CD8 T cells.
The same study also suggested that uninfected erythrocytes taken
from anemic rats show normal clearance in uninfected rats, but we
find that anemia is intrinsic to the infected spleen. Prior evidence
indicates that CD8 and/or CD4 T cells may influence parasite
biomass/infection in P. berghei and other malarias in rodents (29–
33). Our data from the rat model show that the CD8 T cells
regulate parasite clearance and anemia as an adaptive (rather than
an innate) immune response in the spleen. In future studies, sple-
nectomized rats may be used to further confirm the key role of the
spleen, with the caveat that circulating parasitemias may be sub-
stantially higher.
With respect to mechanisms of anemia, our depletion experi-
ments suggest that CD4-activated NK cells are not likely to be
involved in parasite killing. Rather CD8 T cell-induced parasite
clearance may generate an intermediate(s) that stimulates innate
clearance mechanisms of macrophages to trigger erythrocyte re-
moval in the spleen (Fig. 5C). Moreover, infection changes prop-
erties of a large number of uninfected erythrocytes. This may fur-
ther facilitate their uptake by activated macrophages as well as
limit filtration through the splenic sinusoids, resulting in entrap-
ment in the RP, and thus additionally potentiate clearance there
(Fig. 5C). This may be due to steric or antigenic changes in unin-
fected erythrocytes that may be investigated in in vitro studies.
Thus, although their exact nature has yet to be determined,
changes in uninfected-erythrocyte properties may signify mecha-
nisms of removal in the spleen analogous to those seen with in-
herited anemias (34).
FIG 6 Total parasite burden and sCD8 as correlates of SMA in a case-control pediatric cohort infected with P. falciparum. (A) Diagrammatic representation of
patient groups, with numbers of children and PCV cutoffs used to assign them to the SMA group and the uncomplicated malaria (UM) group (which was further
subdivided into patients with acute infection and no malarial anemia [AINMA] and mild malarial anemia [MMA]). (B) For each patient group, clinical
parameters and plasma levels of PfHRP2, from which the total parasite burden (Tot. Par. Bdn) and sequestration index (from the expected PfHRP2 level) were
calculated as previously described (6, 7, 45) (section I), and sCD8 (section II). Cir. Par. Bdn, circulating parasite burden.
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Upon parasite clearance in humans, CD8 T cell responses are
clearly directly elicited by liver-stage infection (20, 21, 35, 36).
Activation by blood-stage infection has also been suggested (36,
37). In our studies, the infections bypass the liver stage. Prior
studies suggest that murine CD8 T cells recognize blood-stage
rodent malaria parasites (22, 38). Dendritic cells may contribute
and be present in preparations of CD8T cells (but in our studies,
immunodepletion of animals with anti-CD8 did not deplete
CD8 dendritic cells). There may be additional mechanisms of
activation, such as exosomes derived from infected reticulocytes
(39). We find that the increase in CD8 T cells is directly propor-
tional to parasite biomass in the spleen. We find sCD8 to be a
strong surrogate for CD8 T cells. Since the plasma volumes re-
quired are small, dual assessment of sCD8 and PfHRP2 parasite
burden may be readily expanded to larger clinical studies for iden-
tification of patients at greatest risk for SMA.
In malaria, anemia requires persistent parasite clearance, likely
ongoing in semi-immune parasitemic individuals. Our work
shows that in pediatric patients, the CD8 host response can in-
dependently increase the risk of SMA. Moreover, the host re-
sponse and parasite burden can be synergized in severe-disease
predictions. It will be important to engineer a highly protective
CD8 T cell response in the presence of minimal parasite loads to
reduce the risk of anemia, which has been frequently associated
with the challenge phase of testing malaria vaccines (40–42).
MATERIALS AND METHODS
Wistar rat model of P. berghei infection and anemia. BALB/c mice were
first injected intraperitoneally (i.p.) with thawed stabilates of blood-stage
P. berghei ANKA. Subsequently, live parasites isolated from mice were
used to infect aged Wistar rats. Fifteen-week-old rats were injected i.p.
with 106 wild-type or msp7 mutant parasites (10). Parasitemia, hemo-
globin, and other blood parameters were monitored every 2 days. Parasite
levels were monitored by performing Giemsa staining of thin blood film
or qPCR, and hemoglobin (Hb) levels were determined by the method of
Drabkins (as noted in reference 10).
Microarray experiments anddata analysis.Spleens from 2 wild-type-
parasite-infected, 2 msp7 mutant-infected, and 2 uninfected rats (15
weeks of age) were surgically harvested, kept in RNAlater, and stored at
20°C until used. RNA was isolated using a Roche MagNA Pure compact
automated system, and labeling was done using a MessageAmp Premier
RNA amplification kit (Invitrogen). Affymetrix rat 430 2.0 array hybrid-
izations were performed by the UCLA Clinical Microarray Core, UCLA,
Los Angeles, CA, according to the standard Affymetrix GeneChip expres-
sion analysis protocol. RNA from each animal was profiled individually.
Thresholds for selecting significant genes were set at a relative difference
of1.5-fold, an absolute difference of100 signal intensity units, and a P
of 0.05. Genes that met all three criteria were considered significantly
changed.
General histopathology and analysis. Spleen, liver, lung, brain, and
kidney were harvested from rats not infected or infected with wild-type or
msp7 parasites. Harvested organs were cut into smaller portions and
placed into fixative (10% neutral buffered formalin) for at least 48 h at
room temperature. Samples were then processed and paraffin embedded
at AML Laboratories Inc. (Baltimore, MD), and thin sections (3 to 4m)
were produced with a microtome and stained with hematoxylin and eosin
(H&E).
Immunohistochemistry and imaging.Mouse monoclonal antibodies
(MAbs) utilized were anti-rat (i) CD8 (clone OX-8, catalog no.
MCA48G), (ii) CD4 (clone W3/25, no. MCA55R), (iii) CD68 (clone ED1,
no. MCA341R; AbD Serotec, Oxford, United Kingdom), and (iv) OX 62
for dendritic cells (DC) (clone OX-62, no. MCA1029GA; AbD Serotec,
Oxford, United Kingdom; also referred to as anti-DC). Formalin paraffin-
embedded spleen or liver sections (3 to 4m) were dewaxed in xylene. For
samples probed by MAbs anti-CD4, anti-CD68, and anti-DC, antigen
retrieval required preincubation of deparaffinized samples with 0.05%
proteinase K (Dako, Hamburg, Germany; no. S3004) in 0.05 mol/liter
Tris-HCl (pH, 7.5) for 8 min at room temperature (RT). After being
washed, sections were immersed in 3% H2O2 in phosphate-buffered sa-
line (PBS) for 20 min at RT to block endogenous peroxidase. After an
additional wash, the sections were treated with 5% horse serum for
30 min, followed by successive incubation in avidin and biotin (no. SP-
2001 avidin/biotin blocking kit; Vector Laboratories) to block endoge-
nous biotin. Anti-CD8 (dilution, 1/100), anti-CD4 (dilution, 1/100),
anti-CD68 (dilution, 1/500), or anti-DC (dilution, 1/100) was applied to
the sections in PBS with 1% horse serum and kept overnight at 4°C (for
MAbs anti-CD8, anti-CD4, and anti-DC) or for 60 min at RT (for MAb
anti-CD68). Affinity-purified, biotinylated, and rat absorbed horse anti-
mouse IgG (no. BA-2001) and the Vectastain ABC Elite system for perox-
idase (no. PK 6102) were from Vector Laboratories (Burlingame, VT,
USA). The Ab was used to detect anti-CD8, anti-CD4, anti-CD68, or
anti-DC in all samples. Reagents were prepared according to the manu-
facturers’ recommendations. The peroxidase complexes were revealed by
incubation with 3,3=-diaminobenzidine-tetra-hydrochloride (DAB; sub-
strate no. SK-4100; Vector Laboratories) or Vector NoraRED (no. SK-
4800; Vector Laboratories), and the sections were lightly counterstained
TABLE 1 sCD8 is a risk factor for SMA and shows synergy with
PfHRP2 for development of a dual, preferred, predictive index of SMAa
Characteristic OR CI95% (fold) P value
Sex
Male 1
Female 0.9 0.5–1.8 0.79
Age (yr)
Lower 1
Higher 0.3 0.2–0.6 0.001
Weight (kg)
Lower 1
Higher 0.4 0.2–0.7 0.003
Parasitemia (%)
Lower 1
Higher 1.4 0.7–2.8 0.29
Plasma PfHRP2 (ng/ml)
Lower 1
Higher 3.5 1.7–7.1 0.0005
Plasma sCD8 (g/ml)
Lower 1
Higher 2.4 1.0–5.7 0.04
Circulating parasite biomass
Lower 1
Higher 0.8 0.4–1.6 0.58
Total parasite biomass
Lower 1
Higher 3.7 1.8–7.5 0.0004
Plasma samples with CD8-PfHPR2
Lower-lower 1
Higher-lower 2.2 0.5–9.3 0.30
Lower-higher 2.8 0.6–12.1 0.17
Higher-higher 7.2 1/9/27.4 0.004
Multivariate logistic regression
Plasma samples with CD8-PfHPR2
Lower-lower 1
Higher-lower 2.1b 0.5–8.9 0.33
Lower-higher 2.6b 0.6–11.4 0.20
Higher-higher 6.7b 1/7/25.7 0.006
a Univariate logistical-regression analysis was undertaken to determine the odds ratio
(OR) associated with the risk of SMA for age, weight, PfHRP2 level, estimated total
parasite biomass, circulating parasites in the blood, and plasma sCD8.
b Adjusted values were used for age and weight.
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with Mayer’s hemalum. The slides were then mounted in Cytoseal XYL
(no. 8312-4; Thermo Scientific, Kalamazoo, MI, USA). Incubations for
negative controls were carried out with sections incubated with normal
mouse IgG1 (no. MCA1209; AbD Serotec, Oxford, United Kingdom) or
in the absence of the primary antibody.
For each spleen slide, images were collected within the follicle (white
pulp [WP]) and the adjacent marginal zone (MZ; marginal sinus in-
cluded) and red pulp (RP). Follicles with a clear differentiation between
the white pulp, the adjacent MZ, and the RP were selected for imaging.
The collection of the images was done at a magnification of1,000 (high-
power fields [HPF]). The images of all areas of the follicle and the adjacent
MZ were collected, while at least 10 randomly selected fields in the adja-
cent RP around the follicle were collected. Pictures were acquired on a
Nikon Olympus microscope using a Nikon digital DS-Fi1-U2 camera
controlled by NIS-Elements F3.0 Nikon software (all from Nikon Instru-
ments Inc., Tokyo, Japan). Images were visualized with a DPIan Apo
40/1.00 oil immersion or a DPIan Apo 100/1.30 oil immersion objec-
tive lens (Nikon). For each sample, positive cells were counted and local-
ized on at least two follicles with the adjacent MZ and RP.
For each liver slide, images were collected within the entire tissue
sample at a magnification of1,000. For each type of cellular stain (CD8
T cells, CD4 T cells, CD68 cells, or DC), more than 600 photographs
were analyzed. The densities of CD8 T cells, CD4 T cells, CD68 cells,
or DC were estimated as the number of positive cells per HPF.
Live-cell immunofluorescence assay. Fluorescein isothiocyanate
(FITC) mouse monoclonal anti-rat RT1A (clone OX-18, catalog no.
554919; BD Biosciences, USA) was used to detect MHC class I. Phyco-
erythrin (PE) mouse anti-rat CD71 (clone OX-26, no. 554891) was used
to detect rat CD71. Fresh blood was collected, washed with PBS (pH 
7.4), and then incubated with anti-RT1A and anti-CD71 (4 g/ml) di-
luted in PBS-bovine serum albumin (BSA; 2%) for 30 min on ice under
slight agitation. After five washes with PBS, cell nuclei were stained with
4=,6-diamidino-2-phenylindole (DAPI) for 5 min. Cells were then washed
with PBS and fixed with PBS-formaldehyde (1%). Slides were mounted
with Vectashield medium (Vector Laboratories, Burlingame, CA) for im-
aging. Images were visualized with a 100 oil immersion objective lens
and captured using an inverted Olympus IX fluorescence microscope and
a CoolSnap HQ2 charge-coupled-device (CH350/LCCD) camera con-
trolled by DeltaVision software (Applied Precision, Seattle, WA).
Percoll density gradients. Discontinuous Percoll density gradients
(Sigma-Aldrich, St. Louis, MO, USA) consisting of 1.5-ml fractions, with
densities ranging from 48 to 64% Percoll in RPMI medium, were assem-
bled as indicated in Fig. 5A. Peripheral blood was collected from unin-
fected and infected animals, washed three times, and diluted in RPMI
medium (hematocrit 80%). From this suspension, 1 ml was layered on
the Percoll gradient and separated by centrifugation at 3,000 rpm for
40 min at 19°C. Fractions were collected by careful pipetting. The number
of cells per fraction was counted using a Malassez chamber.
RNA extraction. For each spleen sample, three sections (5 m each)
separated by 50 m were collected and pooled for RNA extraction. Total
RNA was extracted with an RNeasy FFPE kit (reference no. 73504; Qia-
gen) according to the manufacturer’s instructions. RNA extracts were
quantified using a NanoDrop ND-1000 (NanoDrop Technologies, Wil-
mington, DE, USA). The integrity of the RNA was controlled with an RNA
nano chip (2100 Bioanalyzer; Agilent Biotechnologies, Wilmington, DE).
Samples were immediately stored at20°C.
Quantitative real-time PCR. Primers were designed from the P. ber-
ghei Anka 18S rRNA gene (GenBank accession no. AJ243513.1) and the
rat GAPDH (glyceraldehyde-3-phosphate dehydrogenase) gene (Gen-
Bank accession no. NM_017008). The sequence of the specific primers for
P. berghei 18S RNA and rat GAPDH were 18S RNA forward (5= AATCT
TGAACGAGGAATGCCTAGT 3=), 18S RNA reverse (5= ACGGGCGGT
GTGTACAAAG 3=), GAPDH forward (5= TGGCCTCCAAGGAGTAAG
AAAC 3=), and GAPDH reverse (5= GGCCTCTCTCTTGCTCTCAGTAT
C 3=). Amplification of the GAPDH sequence served as the internal
control for normalization. qPCR was performed using the 7900 HT Fast
real-time PCR system (Applied Biosystems) with a 20-l reaction volume
and the Power SYBR Green RNA-to-CT one-step kit (catalog reference
no. 4389986; Applied Biosystems). Serial dilutions of the cDNA (1:1, 1:10,
1:100, 1:1,000, 1:10,000) with nuclease-free water (reference no. AM9935;
Applied Biosystems) were used to generate a relative standard curve for
18S RNA as well as GAPDH. The concentrations of target sequence in the
samples are extrapolated from the standard curve. The quantities were
normalized by dividing the quantity of the 18S RNA by the quantity of the
GADPH.
Spleen lymphocyte isolation and characterization by flow cytom-
etry. To isolate lymphocytes, spleens were harvested from rats infected
with wild-type and msp7 mutant parasites on day 8 and day 10. Total
splenocytes were isolated, erythrocytes were lysed, and residual cells were
stained for B (CD45RA), NK (CD161a), and CD3 (CD4 and CD8) cells.
Subsets of cells were identified by first gating them on lymphocytes by
forward and side scatter. CD3 singly positive cells were then analyzed for
CD4 and CD8 expression. A suitable isotype control for each antibody was
included as a control, and compensation was performed wherever re-
quired. Events were recorded in a Beckman Coulter FC500 flow cytometer
and data analyzed with FlowJo.
In vitro stimulation of CD8T cells withwild-type parasites.Whole
blood was separated in two parts, one for peripheral blood mononu-
cleated cells (PBMCs) and CD8 T cell purification and the other part for
infected-erythrocyte purification. Erythrocytes were lysed with NH4Cl,
and the cells were washed twice in fresh medium. CD8 T cells were
purified with positive selection using a magnetically activated cell sorting
(MACS) cell separation system (Miltenyi Biotech, USA) according to the
manufacturer’s protocols. The purity of CD8T was 95%. Infected eryth-
rocytes were obtained as described previously (43).
For the in vitro stimulation assay, 106 purified CD8 T cells were
stimulated with 105 purified infected erythrocytes (with ~40% infected
reticulocytes) suspended in 200 l incubation medium (RPMI 1640 plus
L-glutamine plus neomycin plus 30% fetal bovine serum) for 72 to 82 h,
and the levels of IFN- in the supernatant were determined by a sandwich
enzyme-linked immunosorbent assay (ELISA). Uninfected erythrocytes
and staphylococcal enterotoxin B antigen (SEB; 5 g/ml; Sigma) were
used as negative and positive controls, respectively.
Animal procedures. Animal protocols were reviewed and approved
by the institutional animal care and use committees of Northwestern Uni-
versity (protocol no. 2006-0935) and the University of Notre Dame (pro-
tocol no. 11-070).
Ethics statement. Parents or guardians of study participants gave in-
formed written consent. The research was approved by the internationally
accredited joint ethics committees of the College of Medicine of the Uni-
versity of Ibadan and the University College Hospital, Ibadan, Nigeria. All
procedures with human subjects were approved by the Institutional Re-
view Board of the University of Notre Dame.
Patient study design and sample collection. All study participants of
this case-control study were recruited during 2009 to 2012. Children with
malaria were recruited by the Childhood Malaria Research Group
(CMRG) at the University College Hospital (UCH), Ibadan, Nigeria.
Community control (CC) children (malaria negative) were recruited
from local vaccination clinics and school visits from multiple districts of
Ibadan.
The children were from 6 months to 13 years old. They were screened
for parasite detection by microscopy following Giemsa staining of thick
and thin blood films as performed routinely at the UCH. Clinical defini-
tions used were as indicated by the WHO criteria for severe P. falciparum
malaria (44). All infected children were positive for P. falciparum. Un-
complicated malaria (UM) cases were additionally defined as febrile with
a PCV (packed cell volume) of20% (not requiring hospital admission).
Severe malarial anemia (SMA) cases showed PCVs of16%. CC children
appeared healthy, without any disease symptoms. They wereP. falciparum
negative in both thick and thin Giemsa smears and selected for age and sex
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match with the patient group. The clinical data were compiled for each
patient; blood samples were collected in an EDTA tube, and the plasma
was separated (1,000 g, 10 min), aliquoted, and frozen at80°C until
used.
Quantitative analyses of PfHRP2, parasite biomass, the sequestra-
tion index, and sCD8. The quantification of P. falciparum histidine-rich
protein 2 (PfHRP2) in the plasma of malaria patients was carried out by
sandwich ELISA essentially as previously described (6). Briefly, the mouse
monoclonal Ab anti-P. falciparum HRP2 IgM (MPFM-55A; Immunology
Consultants Laboratory Inc., USA) and horseradish peroxidase (HRP)-
conjugated anti-P. falciparum IgG (MPFG-55P; Immunology Consul-
tants Laboratory Inc., USA) were used for plate coating and for detection,
respectively. The detection limit of the assay was 31.25 pg/ml. Positive
cases were defined as those in which duplicate derived concentrations
were greater than the detection limit. Each ELISA plate contained samples
from UM patients and from age-matched SMA patients.
Circulating and whole-body parasite biomasses were calculated using
the previously reported formulas (6, 7). Total parasite biomass was calcu-
lated only from individuals with detectable PfHRP2 in the plasma. The
sequestration index was calculated as the total parasite burden divided by
the circulating burden (45).
Plasma sCD8 ELISA. Plasma quantification of sCD8 was done by a
sandwich ELISA using the mouse monoclonal antibody anti-human
CD8 (clone D-9, sc-7970; Santa Cruz Biotechnology, Inc.), which rec-
ognizes both human and rat sCD8, as the primary antibody and the rabbit
polyclonal antibody anti-human CD8 (clone H-160, sc-7188; Santa
Cruz Biotechnology, Inc.) as the secondary antibody; these were detected
by the HRP-conjugated goat polyclonal Ab anti-rabbit IgG (HL) (PI-
1000; Vector Laboratories). Each ELISA plate contained samples from CC
patients and from age-matched UM and SMA patients.
Statistical analysis. The Wilcoxon signed-rank test for matched pairs
was used to compare continuous outcomes at different time points. The
Mann-Whitney U test, Student’s t test, Kruskal-Wallis test, or one-way
analysis of variance (ANOVA) with a Tukey or Bonferroni post hoc anal-
ysis was used to compare continuous outcomes of different groups at the
same time point. The correlation between different continuous measures
was determined using the Spearman correlation coefficient.
SMA risk factors were evaluated using univariate and multivariate
logistic-regression models. The binary outcome (yes/no) was a dependent
variable. Eight independent variables were studied: sex, age, body weight,
peripheral parasitemia, plasma concentrations of PfHRP2 and sCD8, and
the estimated circulating and total parasite biomasses. Apart from sex, all
independent variables were coded as binary (high or low according to the
median). Since in the rat model we show that concomitant increases of
parasite clearance and CD8 T cell number predict anemia, we defined
another independent variable, which is the combination of plasma con-
centrations of PfHRP2 and sCD8. This last variable has 4 classes according
to the median (low and high for plasma concentrations of both sCD8 and
PfHRP2, low plasma concentrations of sCD8 and high concentrations of
PfHRP2, and high plasma concentrations of sCD8 and low concentrations
of PfHRP2). The effects of independent variables for the risk of developing
SMA were evaluated using unconditional univariate regression analysis.
The factors significant at a level of 0.05 in the univariate analysis were then
included in a multivariate logistic model. All statistical analyses were per-
formed with SPSS statistical software (PASW statistic version 18). All
P values were two sided, and those0.05 were considered significant.
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